Aspira Pathlab & Diagnostics Ltd
Incorporated in 1973, Aspira Pathlab & Diagnostics Ltd is in the business of pathology and related healthcare services[1]
- Market Cap ₹ 70.5 Cr.
- Current Price ₹ 68.5
- High / Low ₹ 107 / 25.0
- Stock P/E 83.0
- Book Value ₹ 10.9
- Dividend Yield 0.00 %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 6.31 times its book value
- Promoter holding is low: 18.4%
- Promoter holding has decreased over last 3 years: -17.9%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | TTM | |
|---|---|---|
| 13.20 | 20.05 | |
| 14.75 | 18.13 | |
| Operating Profit | -1.55 | 1.92 |
| OPM % | -11.74% | 9.58% |
| 0.42 | 0.41 | |
| Interest | 0.00 | 0.00 |
| Depreciation | 1.54 | 1.51 |
| Profit before tax | -2.67 | 0.82 |
| Tax % | 0.00% | |
| -2.67 | 0.85 | |
| EPS in Rs | -2.59 | 0.82 |
| Dividend Payout % | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | 5% |
| 1 Year: | 122% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | |
|---|---|
| Equity Capital | |
| Reserves | |
| Total Liabilities | |
| CWIP | |
| Investments | |
| Total Assets |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | |
|---|---|
| Net Cash Flow |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | |
|---|---|
| Debtor Days | |
| Inventory Days | |
| Days Payable | |
| Cash Conversion Cycle | |
| Working Capital Days | |
| ROCE % |
Documents
Announcements
-
Updation In Contact Details Of The Company Registrar And Share Transfer Agent
2d - Updated email and website of Aspira Pathlab's Registrar and Share Transfer Agent.
-
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
15 Apr - Company not classified as Large Corporate under SEBI norms.
-
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
15 Apr - Company not classified as Large Corporate under SEBI circular.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
9 Apr - Compliance Certificate in accordance with regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2025
-
Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
8 Apr - Filed Writ Petition for recovery of dues from BMC.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
Company is in the business of running, owning, managing and administering Diagnostics Centers in Mumbai